Setareh Shamsili

Chief Executive Officer & Chief Marketing Officer Coretag

Seminars

Tuesday 11th November 2025
Characterising Key Attributes of an Ideal Radiopharmaceutical Target for Alignment with Radiotherapeutic Properties
1:30 pm
  • Evaluating receptor expression profiles and proximity to radiosensitive tissues
  • Defining target selection criteria based on emission characteristics of alpha versus. beta emitters
  • Exploring strategies for stromal and internalising target engagement, including FAP-directed approaches
Setareh Shamsili, Chief Executive Officer & Chief Marketing Officer, Coretag